Reference
Kollipara VK, et al. Alectinib (ALK inhibitor) induced interstitial lung disease. American Journal of Respiratory and Critical Care Medicine 199: (plus poster) abstr. A6270, No. 9, May 2019. Available from: URL: https://www.atsjournals.org/doi/pdf/10.1164/ajrccm-conference.2019.199.1_MeetingAbstracts.A6270 [abstract]
Rights and permissions
About this article
Cite this article
Alectinib/crizotinib. Reactions Weekly 1787, 23 (2020). https://doi.org/10.1007/s40278-020-73661-y
Published:
Issue Date:
DOI: https://doi.org/10.1007/s40278-020-73661-y